| Literature DB >> 31315687 |
Gokhlesh Kumar1, Karin Hummel2, Ebrahim Razzazi-Fazeli2, Mansour El-Matbouli3.
Abstract
Yersinia ruckeri is the causative agent of enteric redmouth disease in salmonids. In fish, the intestine represents an important site of nutrient uptake, host-pathogen interactions, and defense. The posterior intestine can be inflamed, reddened, and filled with an opaque, yellowish fluid during Y. ruckeri infection. Herein, we report an investigation on the proteome alteration in the posterior intestinal mucosa of rainbow trout (Oncorhynchus mykiss) after exposure to Y. ruckeri. The intestinal mucosal proteins were identified and quantified by a shotgun proteomic approach by applying data-independent quantification with sequential windowed acquisition of all theoretical mass spectra (SWATH). A total of 437 proteins were found to be differentially up- or downregulated in the posterior intestine. Gene ontology of upregulated proteins pointed to their involvement into exopeptidase, endopeptidase, and hydrolase activities, while the downregulated proteins were involved in lipid metabolism, actin binding, and translation processes. Additionally, upregulated proteins were predicted to be involved in lysosome, oxidative phosphorylation, and metabolic pathways, while downregulated proteins were implicated in focal adhesion, regulation of actin cytoskeleton, protein digestion and absorption pathways. This study showed that Y. ruckeri infection can alter protein abundance involved in serine-type carboxypeptidase, cysteine and aspartic-type endopeptidases, metallopeptidases, antioxidant defense, calcium ion binding, glycolytic and carbohydrate metabolic processes in the proteome of the intestinal mucosa of rainbow trout.Entities:
Year: 2019 PMID: 31315687 PMCID: PMC6637484 DOI: 10.1186/s13567-019-0673-8
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1Rainbow trout showing clinical signs of enteric redmouth disease. A Hemorrhages in the caudal and anal fins (arrows). B Enlarged spleen and reddened intestine (arrow), and C rainbow trout at 28 days post-exposure.
Figure 216S rRNA copy numbers in the posterior intestine of rainbow trout. Quantitative real-time PCR shows the mean copy numbers of 16S rRNA gene in the exposed posterior intestine samples. There were significant differences of copy numbers of Y. ruckeri between time points (p value = 0.001), and between biotype 1 and biotype 2 (p value = 0.01). No Y. ruckeri was detected in unexposed control posterior intestine samples at any time point. Error bars indicate standard deviation (n = 9).
List of upregulated posterior intestine proteins of rainbow trout in response to strains
| Accession Refseq | Protein name | Number of quantified peptides | Biological process | Intestine in response to | 3 dpe (fold change) | 9 dpe (fold change) | 28 dpe (fold change) |
|---|---|---|---|---|---|---|---|
| XP_021441860.1 | Probable serine carboxypeptidase CPVL | 6 | Serine-type carboxypeptidase activity | Biotype 1 | 3.6* | −1.7 | 1.4 |
| Biotype 2 | 4.9* | −1.3 | 1.4 | ||||
| XP_021462823.1 | Dipeptidase 1 | 6 | Metallodipeptidase activity | Biotype 1 | 2.1* | 1.3 | −1.0 |
| Biotype 2 | 2.7* | 1.5 | −1.2 | ||||
| XP_021442206.1 | Xaa-Pro dipeptidase | 6 | Metallopeptidase activity | Biotype 1 | 2.4* | −1.1 | 1.2 |
| Biotype 2 | 3.1* | 1.1 | 1.2 | ||||
| XP_021437213.1 | Dipeptidyl peptidase 1 | 5 | Cysteine-type endopeptidase activity | Biotype 1 | 1.8 | 1.2 | 1.9 |
| Biotype 2 | 2.3* | 1.3 | 1.5 | ||||
| XP_021460613.1 | Cathepsin D isoform X1 | 6 | Aspartic-type endopeptidase activity | Biotype 1 | 2.4* | −1.1 | 1.2 |
| Biotype 2 | 3.2* | 1.1 | 1.2 | ||||
| XP_021427100.1 | Pro-cathepsin H | 5 | Aminopeptidase activity | Biotype 1 | 4.3* | −2.0 | 1.3 |
| Biotype 2 | 6.3* | −1.3 | 1.0 | ||||
| XP_021430445.1 | Cathepsin L1 | 6 | Cysteine-type endopeptidase activity | Biotype 1 | 4.3* | −2.4 | 1.3 |
| Biotype 2 | 5.9* | −1.4 | 1.1 | ||||
| XP_021430112.1 | Acid phosphatase type 7 | 6 | Acid phosphatase activity | Biotype 1 | 2.5* | 1.1 | 1.8 |
| Biotype 2 | 4.4* | 1.7 | 1.3 | ||||
| XP_021457257.1 | Lysozyme C II | 5 | Hydrolase activity | Biotype 1 | 2.6* | 2.2* | 1.4 |
| Biotype 2 | 2.8* | 1.6 | 1.1 | ||||
| XP_021478264.1 | Macrophage mannose receptor 1 | 5 | Endocytosis | Biotype 1 | 3.2* | −1.1 | 1.3 |
| Biotype 2 | 4.7* | 1.4 | 1.2 | ||||
| XP_021446773.1 | Eosinophil peroxidase | 6 | Peroxidase activity | Biotype 1 | 3.2* | −1.2 | −1.1 |
| Biotype 2 | 1.6 | −1.4 | −1.2 | ||||
| XP_021424232.1 | Thioredoxin reductase 1 | 4 | Redox homeostasis | Biotype 1 | 1.7 | 1.1 | 1.1 |
| Biotype 2 | 2.2* | 1.0 | 1.1 | ||||
| XP_021412083.1 | Lysosomal alpha-mannosidase | 6 | Alpha-mannosidase activity | Biotype 1 | 2.8* | −1.8 | 1.4 |
| Biotype 2 | 4.8* | 1.1 | 1.3 | ||||
| NP_001154031.1 | Glutathione S-transferase A | 6 | Glutathione metabolic process | Biotype 1 | 1.7 | 1.1 | −1.0 |
| Biotype 2 | 2.0* | 1.2 | −1.0 | ||||
| XP_021460921.1 | Peroxisomal multifunctional enzyme type 2 | 6 | Oxidoreductase activity | Biotype 1 | 2.0* | 1.1 | −1.0 |
| Biotype 2 | 2.4* | 1.0 | −1.0 | ||||
| XP_021475660.1 | Endoplasmic reticulum aminopeptidase 1 | 4 | Aminopeptidase activity | Biotype 1 | 1.8 | 1.2 | 1.0 |
| Biotype 2 | 2.2* | 1.0 | −1.0 | ||||
| NP_001117743.1 | Caspase 6 precursor | 2 | Apoptotic process | Biotype 1 | 2.2* | −1.1 | 1.2 |
| Biotype 2 | 2.1* | −1.2 | −1.1 | ||||
| XP_021477916.1 | Interferon-induced GTP-binding protein Mx2 | 5 | GTPase activity | Biotype 1 | 2.0 | 1.3 | −1.1 |
| Biotype 2 | 2.4* | 1.3 | −1.3 | ||||
| XP_021468639.1 | Gamma-interferon-inducible lysosomal thiol reductase | 3 | Antigen processing and presentation | Biotype 1 | 3.0* | −1.9 | 1.4 |
| Biotype 2 | 4.4* | −1.1 | 1.3 | ||||
| XP_021466891.1 | Precerebellin-like protein | 5 | Response to lipopolysaccharide | Biotype 1 | 2.9* | 5.3* | 2.0 |
| Biotype 2 | 2.2 | 3.3* | 1.3 | ||||
| XP_021453615.1 | Calretinin-like | 6 | Calcium ion binding | Biotype 1 | 2.5* | 1.5 | 1.2 |
| Biotype 2 | 3.0* | 1.6 | 1.0 | ||||
| XP_021426220.1 | Regucalcin | 6 | Calcium ion binding | Biotype 1 | 2.1 | 1.0 | 1.4 |
| Biotype 2 | 3.1* | 1.2 | 1.1 | ||||
| XP_021480508.1 | Ras-related protein Rab-5C | 4 | GTPase activity | Biotype 1 | 1.7 | 1.0 | 1.3 |
| Biotype 2 | 2.4* | 1.1 | 1.0 | ||||
| XP_021477941.1 | Fructose-1,6-bisphosphatase 1 | 3 | Carbohydrate metabolic process | Biotype 1 | 3.8* | 1.4 | 1.0 |
| Biotype 2 | 2.2 | 1.0 | −1.2 | ||||
| XP_021434786.1 | Beta-hexosaminidase | 2 | Carbohydrate metabolic process | Biotype 1 | 2.4* | −1.5 | −1.0 |
| Biotype 2 | 2.5* | −1.1 | 1.2 | ||||
| XP_021467816.1 | Alpha- | 6 | Carbohydrate metabolic process | Biotype 1 | 3.0* | −1.3 | 1.2 |
| Biotype 2 | 4.1* | 1.1 | 1.3 |
Fold change was statistically analyzed in the posterior intestine of rainbow trout exposed to Y. ruckeri biotype 1 (CSF007-82) and biotype 2 (A7959-11) versus control posterior intestine of rainbow trout samples (n = 3 per time point).
* Statistically significant difference according to both ANOVA and post hoc Tukey’s HSD with FDR-adjusted p-value < 0.05 and fold change < −2 or > +2. (Full table is presented in Additional file 4).
List of downregulated posterior intestine proteins of rainbow trout in response to strains
| Accession Refseq | Protein name | Number of quantified peptides | Biological process | Intestine in response to | 3 dpe (fold change) | 9 dpe (fold change) | 28 dpe (fold change) |
|---|---|---|---|---|---|---|---|
| NP_001117719.1 | Apolipoprotein A-I-1 | 6 | Lipid metabolism | Biotype 1 | −1.3 | −1.1 | −1.6 |
| Biotype 2 | −2.2* | −1.2 | −1.1 | ||||
| NP_001154920.1 | Apolipoprotein A-II | 4 | Lipid metabolism | Biotype 1 | −2.1* | −1.0 | −1.7 |
| Biotype 2 | −4.0* | 1.1 | −1.3 | ||||
| XP_021447265.1 | Apolipoprotein C-I | 2 | Lipid metabolism | Biotype 1 | −1.7 | 1.1 | −3.1* |
| Biotype 2 | −4.6* | −1.3 | −2.7 | ||||
| XP_021422847.1 | Filamin-A | 6 | Actin filament binding | Biotype 1 | −3.2* | −2.8 | −1.5 |
| Biotype 2 | −10.4* | −2.8 | −1.4 | ||||
| XP_021438757.1 | Alpha-actinin-1 | 6 | Actin filament binding | Biotype 1 | −2.4* | −1.7 | −1.2 |
| Biotype 2 | −6.3* | −1.9 | 1.3 | ||||
| XP_021474949.1 | PDZ and LIM domain protein 3 | 2 | Alpha-actinin binding | Biotype 1 | −4.2* | −2.5* | −1.1 |
| Biotype 2 | −22.6* | −1.7 | 1.1 | ||||
| XP_021479779.1 | Dihydropyrimidinase-related protein 3 | 6 | Actin filament bundle assembly | Biotype 1 | −2.4* | −1.7 | −1.3 |
| Biotype 2 | −4.5* | −1.6 | −1.1 | ||||
| XP_021449109.1 | Tubulin alpha chain | 3 | Microtubule process | Biotype 1 | −2.1* | 1.2 | −1.8 |
| Biotype 2 | −4.9* | −1.2 | −1.6 | ||||
| XP_021451765.1 | Tubulin polymerization-promoting protein | 6 | Microtubule binding | Biotype 1 | −3.6* | −1.7 | −1.3 |
| Biotype 2 | −7.0* | −1.5 | −1.2 | ||||
| XP_021480500.1 | DnaJ homolog subfamily C member 7 | 2 | Chaperone binding | Biotype 1 | −1.9 | 1.1 | −1.2 |
| Biotype 2 | −3.2* | −1.4 | −1.0 | ||||
| XP_021478259.1 | Lysosome membrane protein 2 | 2 | Chaperone activity | Biotype 1 | −2.6* | 1.1 | −1.3 |
| Biotype 2 | −3.3* | −1.3 | −1.3 | ||||
| NP_001117706.1 | Heat shock 47 precursor | 6 | Stress response | Biotype 1 | −3.7* | −1.4 | −1.1 |
| Biotype 2 | −9.6* | −1.2 | 1.0 | ||||
| XP_021438340.1 | Heat shock cognate 70 kDa protein-like | 6 | Chaperone activity | Biotype 1 | −1.9 | −1.1 | −1.3 |
| Biotype 2 | −2.6* | −1.4 | −1.1 | ||||
| XP_021441996.1 | Programmed cell death protein 5 | 2 | DNA binding | Biotype 1 | −2.7* | 1.2 | −1.7 |
| Biotype 2 | −4.4* | −1.4 | −2.6* | ||||
| XP_021418468.1 | Annexin A13 | 6 | Calcium ion binding | Biotype 1 | −2.0* | −1.6 | −1.8 |
| Biotype 2 | −3.4* | −1.2 | −1.1 | ||||
| XP_021416101.1 | Protein S100 A13 | 2 | Calcium binding | Biotype 1 | −3.2* | −1.1 | −1.5 |
| Biotype 2 | −6.6* | −1.3 | −1.1 | ||||
| NP_001117701.1 | M-calpain | 6 | Calcium ion binding | Biotype 1 | −2.0* | −1.2 | −1.0 |
| Biotype 2 | −4.0* | −1.4 | 1.0 | ||||
| NP_001117963.1 | Calpain 2 catalytic subunit | 5 | Calcium ion binding | Biotype 1 | −1.8 | −1.1 | −1.1 |
| Biotype 2 | −2.6* | −1.0 | −1.0 | ||||
| XP_021419099.1 | 2 | Carboxylic acid metabolic process | Biotype 1 | −3.4* | −1.5 | −1.8 | |
| Biotype 2 | −7.4* | −1.7 | 1.3 | ||||
| XP_021452473.1 | Glyceraldehyde-3-phosphate dehydrogenase | 4 | Glycolysis process | Biotype 1 | −1.8 | −1.2 | −1.3 |
| Biotype 2 | −2.9* | −1.1 | −1.1 | ||||
| XP_021447060.1 | Pyruvate dehydrogenase E1 | 4 | Glucose metabolic process | Biotype 1 | −2.1* | 1.2 | 1.0 |
| Biotype 2 | −1.7 | 1.1 | −1.0 | ||||
| XP_021440913.1 | Galectin-5-like isoform X2 | 2 | Carbohydrate binding | Biotype 1 | −2.3* | 1.0 | 1.1 |
| Biotype 2 | −3.9* | 1.4 | −1.2 | ||||
| XP_021476056.1 | Eukaryotic translation initiation factor 5A | 5 | Translation | Biotype 1 | −1.4 | 1.1 | −1.4 |
| Biotype 2 | −2.4* | −1.3 | −1.6 | ||||
| XP_021467048.1 | 40S ribosomal protein S12 | 5 | Translation | Biotype 1 | −1.1 | 1.4 | −1.2 |
| Biotype 2 | −2.2* | 1.2 | 1.3 | ||||
| XP_021456583.1 | 40S ribosomal protein S29 | 3 | Translation | Biotype 1 | −3.4* | 1.0 | −1.2 |
| Biotype 2 | −2.9* | −1.0 | −1.3 |
Fold change was statistically analyzed in the posterior intestine of rainbow trout exposed to Y. ruckeri biotype 1 (CSF007-82) and biotype 2 (A7959-11) versus control posterior intestine of rainbow trout samples (n = 3 per time point).
* Statistically significant difference according to both ANOVA and post hoc Tukey’s HSD with FDR-adjusted p-value < 0.05 and fold change < −2 or > +2. (Full table is presented in Additional file 4).
Figure 3Classification of differentially up or down-regulated posterior intestine proteins of rainbow trout in response to at 3 dpe. Proteins were classified by gene ontology terms for biological processes, molecular functions, cellular components and protein classes using PANTHER and ClueGO tools. A Biological process, B molecular function, C cellular component, and D protein class.
Figure 4Relative expression levels of probable serine carboxypeptidase, cathepsin D, caspase-6, protein S100 and tubulin alpha in the posterior intestine of rainbow trout. Quantitative real-time PCR shows mean relative expression profiles of each selected gene in the posterior intestine of rainbow trout in response to Y. ruckeri biotype 1 (CSF007-82) and biotype 2 (A7959-11) at different time points. Relative gene expression changes in each gene were determined in the exposed and control posterior intestine samples by the CFX Manager Maestro Software in normalized expression mode (∆∆Cq), using elongation factor alpha 1 as a reference at each time point. A Probable serine carboxypeptidase CPVL, B cathepsin D, C caspase 6, D protein S100, and E tubulin alpha. Stars indicate statistically significant differences in the gene expression compared to the control group. Error bars indicate standard deviation (n = 9).
Figure 5Comparison of transcriptional analysis and MS-based proteomic results of lysozyme C II and precerebellin. The qRT-PCR and the MS-based proteomic results are presented by the bar and line charts, respectively. Stars indicate statistically significant differences in the fold change compared to the control group. Error bars indicate standard deviation (n = 9). A Lysozyme C II, and B precerebellin-like protein.